Valuation: Remus Pharmaceuticals Limited

Market Cap 7.32B 76.67M 66.6M 61.85M 57.04M 107M 109M 732M 287M 3.64B 288M 282M 12.23B P/E 2024
45.4x
P/E 2025 45.4x
Enterprise Value 7.28B 76.23M 66.21M 61.48M 56.7M 107M 109M 728M 285M 3.61B 286M 280M 12.15B EV / Sales 2024
4.69x
EV / Sales 2025 2.12x
Free-Float
24.75%
Yield 2024
0.09%
Yield 2025 0.07%
1 day+0.33%
1 week-0.44%
Current month-7.60%
1 month-7.60%
3 months+5.06%
6 months+11.46%
Current year+2.53%
1 week 705
Extreme 705
730
1 month 705
Extreme 705
810.05
Current year 580
Extreme 580
937
1 year 580
Extreme 580
952
3 years 501.25
Extreme 501.25
1,417.38
5 years 213.91
Extreme 213.9063
1,417.38
10 years 213.91
Extreme 213.9063
1,417.38
Manager TitleAgeSince
Chief Executive Officer 38 2023-01-15
Director of Finance/CFO - 2026-07-08
Compliance Officer - 2023-01-05
Director TitleAgeSince
Director/Board Member 38 2015-09-20
Chairman 41 2015-09-20
Director/Board Member 38 2015-09-20
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-0.44%-22.44%+36.45% 87.63M
-2.02%-6.06%+51.81%+147.17% 1,030B
-0.13%-3.27%+54.66%+52.09% 617B
-2.04%-2.98%+33.13%+68.23% 455B
+0.10%-0.70%+37.15%+30.30% 350B
-0.28%-0.49%+34.07%+38.66% 299B
-0.68%-0.58%+11.23%+12.61% 265B
-7.42%-4.90%-3.05%-44.17% 225B
-1.30%+1.61%+29.48%+63.18% 209B
-0.86%+0.19%+15.37%+70.15% 163B
Average -1.45%+4.09%+24.14%+47.47% 361.28B
Weighted average by Cap. -1.53%+4.87%+37.72%+70.56%

Financials

2024 2025
Net sales 2.13B 22.3M 19.37M 17.98M 16.59M 31.24M 31.81M 213M 83.36M 1.06B 83.73M 81.9M 3.56B 6.2B 64.98M 56.44M 52.41M 48.34M 91.05M 92.7M 621M 243M 3.08B 244M 239M 10.36B
Net income 215M 2.26M 1.96M 1.82M 1.68M 3.16M 3.22M 21.54M 8.43M 107M 8.47M 8.29M 360M 291M 3.04M 2.64M 2.46M 2.27M 4.27M 4.34M 29.08M 11.38M 144M 11.43M 11.18M 486M
Net Debt -178M -1.86M -1.62M -1.5M -1.39M -2.61M -2.66M -17.8M -6.97M -88.39M -7M -6.85M -297M -42.9M -449K -390K -362K -334K -630K -641K -4.29M -1.68M -21.31M -1.69M -1.65M -71.65M
Logo Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Employees
-
Date Price Change Volume
26-07-31 720.00 +0.33% 2,000
26-07-30 ₹717.65 -0.19% 5,300
26-07-29 ₹719.00 +0.61% 2,300
26-07-28 ₹714.65 -0.88% 3,600
26-07-27 ₹721.00 +0.19% 2,200
  1. Stock Market
  2. Stocks
  3. REMUS Stock